If you’ve been using a GLP-1 medication like semaglutide (Ozempic/Wegovy) or tirzepatide (Mounjaro/Zepbound), you probably already know how effective they can be for weight loss. In many cases, these medications help people lose 15–20% or more of their body weight. But what happens after you’ve hit your goal?

Do you have to stay on the full dose forever? For many, the answer may be no.

A growing number of providers—and patients—are exploring the benefits of tapering down to a lower dose of GLP-1 medications for long-term weight maintenance. This isn’t about quitting cold turkey or staying on high doses forever. Instead, it’s about finding a sustainable balance that supports your weight goals, health, and lifestyle.
Let’s talk about what the research says, what doctors are recommending, and how a lower-dose strategy might work for you.

What Happens When You Stop GLP-1 Medications?
First, it’s important to understand what happens when these medications are stopped altogether. One of the best-known studies on this topic, the STEP 1 trial, followed participants who had used semaglutide for over a year. After stopping the medication, participants regained about two-thirds of the weight they had lost within 12 months (Wilding et al., 2022).
That’s a pretty clear message: for most people, GLP-1 medications aren’t a one-and-done fix. Obesity is a chronic condition, and like high blood pressure or diabetes, it often requires long-term management.

So, Is There a Middle Ground?
Rather than staying on a high dose indefinitely or stopping abruptly, researchers and clinicians are exploring lower-dose maintenance strategies. Think of it like stepping down from a therapeutic dose to a “maintenance mode”—still giving your body some metabolic support but with fewer side effects and potentially lower costs.
A Danish study found that participants who tapered their semaglutide dose slowly maintained stable weight over 6 months, while those who stopped the medication altogether began regaining weight (Olesen et al., 2024). Other clinical experiences have shown that some people can maintain their weight with as little as 0.25–1.0 mg of semaglutide per week—significantly lower than the full 2.4 mg dose used during active weight loss.

Why Tapering May Work
GLP-1 medications work by decreasing appetite, slowing stomach emptying, and improving insulin sensitivity. While a full dose creates more dramatic effects, even a lower dose can help maintain some of these benefits, especially when combined with lifestyle changes.
Some of the reasons tapering might work include:

• Gradual metabolic adaptation: Your body has time to adjust, which may prevent the sharp increase in hunger and weight regain that can occur when stopping abruptly.
• Reduced side effects: Nausea, bloating, and constipation are much less common at lower doses.
• Lower costs: For those paying out of pocket, using less medication can make long-term use more affordable.
• Easier insurance navigation: Some providers find it easier to maintain coverage for low-dose prescriptions in the context of chronic disease management.

What the Experts Say

According to the European Association for the Study of Obesity (EASO), tapering GLP-1 therapy should be an integral part of a long-term weight management plan, rather than an afterthought. Their guidance emphasizes pairing any medication changes with continued nutritional, behavioral, and physical activity support (EASO, 2025).
Meanwhile, other studies suggest that continuing on a smaller maintenance dose may be more effective than switching off entirely, especially for those who’ve struggled with yo-yo dieting in the past.

Practical Steps to Transition to a Lower Dose
If you’re considering moving to a lower dose of your GLP-1 medication, it’s essential to do so with the guidance of your healthcare provider. Here’s what that process may look like:

1. Achieve a stable weight: Most clinicians recommend waiting until your weight has plateaued for several months before beginning a dose reduction.
2. Taper slowly: Your provider may suggest stepping down the dose in gradual increments, perhaps from 2.4 mg to 1.7 mg, then to 1.0 mg or even lower, while monitoring your appetite and weight.
3. Reinforce lifestyle habits: Now’s the time to double down on healthy eating, exercise, sleep, and stress management. The medication can help, but it won’t do the work for you.
4. Stay flexible: If weight starts to creep back up or old habits return, your provider might recommend pausing the taper or adjusting the dose again. This isn’t failure—it’s feedback.
5. Monitor your progress: Keep track of your weight, appetite, mood, and energy levels. This data will help you and your provider make informed decisions moving forward.

Is This Strategy Right for Everyone?
Probably not. People who have had significant metabolic changes, like major improvements in insulin resistance, blood sugar control, or fatty liver disease, may need to stay on higher doses longer. Likewise, those with a history of rapid weight regain or emotional eating may need more structure and support during a taper.
But for many, especially those who are highly motivated and committed to lifestyle changes, transitioning to a lower dose can offer a more sustainable path forward—one that protects your progress without putting your body or your budget through unnecessary stress.

Final Thoughts
GLP-1 medications have changed the landscape of obesity treatment, but they’re just one tool in a broader weight management toolbox. If you’ve reached your weight loss goals and are wondering what comes next, tapering to a lower dose may be a smart, sustainable option—one that allows you to maintain the benefits without the full burden of long-term high-dose therapy.
Work closely with your healthcare provider, monitor your body’s signals, and remember: maintaining your progress is just as important, and often harder, than reaching your initial goal.